vs
施乐辉（SNN）与捷迈邦美（ZBH）财务数据对比。点击上方公司名可切换其他公司
施乐辉是总部位于英国沃特福德的跨国医疗设备制造企业，核心产品线覆盖先进伤口护理、关节镜、创伤与临床治疗、骨科重建四大领域，产品销往全球超过100个国家，是全球知名的医疗设备供应商。
捷迈邦美是一家美国上市的医疗设备企业，1927年成立，最初以生产铝制夹板为核心业务，总部设于印第安纳州华沙市，是当地医疗设备产业集群的核心成员，在全球骨科医疗器械领域拥有较高知名度。
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收
SNN
ZBH
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $1.8B | ||
| Q2 24 | — | $1.9B | ||
| Q1 24 | — | $1.9B |
净利润SNNZBH
| Q4 25 | — | $139.4M | ||
| Q3 25 | — | $230.9M | ||
| Q2 25 | — | $152.8M | ||
| Q1 25 | — | $182.0M | ||
| Q4 24 | — | $239.5M | ||
| Q3 24 | — | $249.1M | ||
| Q2 24 | — | $242.8M | ||
| Q1 24 | — | $172.4M |
毛利率SNNZBH
| Q4 25 | — | 64.7% | ||
| Q3 25 | — | 72.1% | ||
| Q2 25 | — | 71.5% | ||
| Q1 25 | — | 71.2% | ||
| Q4 24 | — | 71.0% | ||
| Q3 24 | — | 70.5% | ||
| Q2 24 | — | 71.5% | ||
| Q1 24 | — | 72.9% |
营业利润率SNNZBH
| Q4 25 | — | 6.9% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 14.4% | ||
| Q1 25 | — | 15.3% | ||
| Q4 24 | — | 19.2% | ||
| Q3 24 | — | 15.3% | ||
| Q2 24 | — | 18.1% | ||
| Q1 24 | — | 14.1% |
净利率SNNZBH
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | 11.5% | ||
| Q2 25 | — | 7.4% | ||
| Q1 25 | — | 9.5% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 12.5% | ||
| Q1 24 | — | 9.1% |
每股收益（稀释后）SNNZBH
| Q4 25 | — | $0.71 | ||
| Q3 25 | — | $1.16 | ||
| Q2 25 | — | $0.77 | ||
| Q1 25 | — | $0.91 | ||
| Q4 24 | — | $1.18 | ||
| Q3 24 | — | $1.23 | ||
| Q2 24 | — | $1.18 | ||
| Q1 24 | — | $0.84 |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
